Laxmi Peri
Directeur Technique/Scientifique/R&D chez ABIOMED, INC.
Profil
M. Laxmi N. Peri est vice-président de l'ingénierie chez ABIOMED, Inc. Auparavant, M. Peri a occupé le poste de premier vice-président des opérations chez Zosano Pharma Corp. et celui de vice-président de la technologie et du développement des produits chez Thoratec Corp. Il a obtenu son diplôme de premier cycle à l'université d'État de l'Iowa, un diplôme de premier cycle au National Institute of Technology et un MBA à l'université du Minnesota.
Postes actifs de Laxmi Peri
| Sociétés | Poste | Début |
|---|---|---|
| ABIOMED, INC. | Directeur Technique/Scientifique/R&D | 01/03/2021 |
Anciens postes connus de Laxmi Peri
| Sociétés | Poste | Fin |
|---|---|---|
| ZOSANO PHARMA CORPORATION | Corporate Officer/Principal | 24/03/2016 |
| THORATEC CORPORATION | Directeur Technique/Scientifique/R&D | - |
Formation de Laxmi Peri
| University of Minnesota | Masters Business Admin |
| National Institute of Technology | Undergraduate Degree |
| Iowa State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Thoratec Corp.
 Thoratec Corp. Medical SpecialtiesHealth Technology Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag Acute Circulatory System, HeartMate II, PVAD, IVAD and for pediatric patients PediMag/PediVAS Acute Circulatory System. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures mechanical circulatory products to support the cardiovascular systems of humans and to provide product-related services. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA. | Health Technology |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
